The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
H MulecS Björck

Abstract

Strict glycaemic control has been shown to reduce the risk of developing diabetic nephropathy. In established nephropathy, however, the impact of glycaemic control on prognosis is less clear. Therefore we investigated the effect of long-term glycaemic control on the decline in renal function in insulin-dependent diabetic patients with overt nephropathy. The study was performed at two hospital-based diabetes centres in western Sweden. The study was an observational retrospective follow-up study in 158 insulin-dependent diabetics with proteinuria with a mean (+/-SD) age of 36+/-9 years and a diabetes duration of 22+/-8 years. The change in glomerular filtration rate was measured as 51Cr EDTA clearance for a median of 8 years (range 1-17). Glycaemic control was determined with measurements of glycated haemoglobin A1c. The decline in glomerular filtration rate was 3.8+/-3.7 ml/min/year. The blood pressure was 143/82+/-15/7 mmHg and the mean glycated haemoglobin was 8.7+/-1.6%. The correlation coefficient between glycated haemoglobin and decline in glomerular filtration rate was -0.39 (P<0.0001 ) and between decline in glomerular filtration rate and systolic and diastolic blood pressure -0.17 (P=0.03) and -0.29 (P=0.003) respectivel...Continue Reading

Citations

Apr 11, 2000·The Journal of Maternal-fetal Medicine·G Leguizamon, E A Reece
Mar 20, 2003·Current Diabetes Reports·Carrie A Phillips, Mark E Molitch
Mar 20, 2003·Current Diabetes Reports·Christopher A Newton, Philip Raskin
Nov 13, 2003·Current Diabetes Reports·Aled O Phillips
Sep 5, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Katherine R Tuttle, Pamela W Anderson
Feb 13, 2001·Kidney International·P HovindH H Parving
Apr 12, 2002·The New England Journal of Medicine·Giuseppe RemuzziPiero Ruggenenti
Apr 9, 2010·Seminars in Dialysis·Csaba P KovesdyKamyar Kalantar-Zadeh
Jan 15, 2004·PharmacoEconomics·Jonathan D RippinStephen C Bain
May 26, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Olga VasovićDanijela Dragković
Jan 9, 2014·Diabetes Research and Clinical Practice·Wang ZhiqingHu Sanyuan
Oct 17, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN National Kidney Foundation
May 3, 2014·Kidney International·Mark E MolitchCarl E Mogensen
Nov 24, 2011·Endocrinology and Metabolism Clinics of North America·Elisabeth R MathiesenPeter Damm
Jun 24, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Csaba P KovesdyKamyar Kalantar-Zadeh
Sep 14, 2007·Pediatric Diabetes·Lorenzo PasqualiSteven Ringquist
Feb 19, 2011·Expert Opinion on Pharmacotherapy·Elisabeth R MathiesenPeter Damm
Oct 27, 2001·Diabetes Care·P HovindH H Parving
Mar 5, 2016·Journal of the American Society of Nephrology : JASN·Akari InadaYo-Ichi Nabeshima
Apr 4, 2003·Diabetes/metabolism Research and Reviews·Giacomo DeferrariValeria Berruti
Jul 26, 2015·Journal of the American Society of Nephrology : JASN·Bernadette ThomasMohsen Naghavi
Jun 7, 2014·Journal of the American Society of Nephrology : JASN·Jan SkupienAndrzej S Krolewski
Jun 14, 2014·Journal of the American Society of Nephrology : JASN·Ian H de BoerUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group
Nov 21, 2008·Postgraduate Medicine·Ahmed H AbdelhafizMeguid El Nahas
Jan 9, 2007·The American Journal of Clinical Nutrition·Christelle RaffaitinVincent Rigalleau
Jan 30, 2007·Diabetes Care·Richard A ChudleighDavid R Owens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.